| Lung Cancer |
1 |
1 |
| Genomic Medicine |
0 |
0.97 |
| Skin and Soft Tissue Infection |
0 |
0.74 |
| Biologic Therapy |
0 |
0.67 |
| EGFR Inhibitor |
0 |
0.62 |
| Epidermal Growth Factor Receptor |
0 |
0.99 |
| Acne |
0 |
0.49 |
| Small Cell Lung Cancer |
0 |
0.98 |
| Cancer |
0 |
0.33 |
| Targeted Cancer Therapy |
0 |
0.32 |
| Toxicology |
0 |
0.28 |
| Face |
0 |
0.25 |
| Lung |
0 |
0.25 |
| Paronychia |
0 |
0.25 |
| Receptors |
0 |
0.25 |
| Scalp |
0 |
0.25 |
| Tyrosine Kinase Inhibitor |
0 |
0.24 |
| Monoclonal Antibody |
0 |
0.17 |
| Pruritus |
0 |
0.17 |
| Pyogenic Granuloma |
0 |
0.17 |
| Tyrosine Kinase |
0 |
0.17 |
| Xeroderma |
0 |
0.17 |
| Dermatitis |
0 |
0.14 |
| Topical Corticosteroid |
0 |
0.12 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Staphylococcal Infection |
0 |
0.09 |
| Board Certification |
0 |
0.08 |
| Cervical Region |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Corticosteroids |
0 |
0.08 |
| Hair |
0 |
0.08 |
| Moisturization |
0 |
0.08 |
| Mucositis |
0 |
0.08 |
| Nail |
0 |
0.08 |
| Onycholysis |
0 |
0.08 |
| Palmar |
0 |
0.08 |
| Prognosis |
0 |
0.08 |
| Staphylococcus Aureus Infection |
0 |
0.08 |
| Sunscreen |
0 |
0.08 |
| Thorax |
0 |
0.08 |